Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cholesterol efflux pathway refers to the cellular processes responsible for exporting excess cholesterol from cells, particularly macrophages, to extracellular acceptors such as high-density lipoprotein (HDL). This is a critical first step in reverse cholesterol transport (RCT), which ultimately leads to the removal of cholesterol from peripheral tissues and its excretion by the liver. Efficient cholesterol efflux is essential for maintaining cellular lipid homeostasis and preventing atherosclerosis.
Enhancing cholesterol efflux, particularly ABCA1-mediated export, to promote reverse cholesterol transport and reduce plaque formation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cholesterol Efflux Pathway.